Pharmaceutical Quality Compliance & Recall Management SaaS
The Opportunity
Telangana's DCA has identified that substandard medicines (NSQ drugs) reach patients due to slow manual recall processes. Pharmacies currently lack real-time alerts and systematic tracking of recalled medicines, creating public health risks and regulatory non-compliance. The newly launched SMS alert system reveals acute demand for digital compliance infrastructure across Indian pharmacy networks.
Market Size
₹800 crore–₹1,200 crore (India has ~900,000 registered pharmacies; compliance software adoption is <5%, creating a greenfield market; estimated ₹1–1.5 lakh per pharmacy annually for digital recall & inventory management)
Business Model
B2B SaaS subscription platform serving pharmacy chains, wholesale distributors, and regional drug control bodies. Provide real-time NSQ drug alerts, automated inventory quarantine, patient recall notifications, and compliance reporting dashboards.
Subscription fees (₹500–₹2,000 per pharmacy/month depending on tier); API integration fees for state health departments (₹10–₹50 lakh annually per state); premium compliance audit reports (₹5–₹20 lakh per client annually)
Your 30-Day Action Plan
Contact Telangana DCA, Tamil Nadu, and Karnataka drug control authorities to understand SMS system pain points and unmet needs; identify 5 pharmacy chains willing to pilot
Map existing NSQ drug database structures and alert protocols; design minimal viable SaaS interface (alert dashboard, inventory quarantine, audit logs)
Develop prototype API to ingest DCA SMS feeds and auto-populate pharmacy dashboards; conduct 2 pilot demos with pharmacy chains
Secure letters of intent (LOI) from 2–3 pharmacy chains and 1 state health authority; finalize pricing model and compliance roadmap
Compliance & Regulatory Angle
Register as software company under GST (5% on SaaS); obtain data security certification (ISO 27001) for handling medicine data; align with Pharmacy Council of India (PCI) guidelines and state drug control regulations; ensure HIPAA-equivalent patient data privacy; obtain MoUs with state excise/drug authorities for data-sharing permissions
Ready to Act on This Opportunity?
Generate a 7-step execution plan — validate the market, build the MVP, model the financials, map the risks, and ship in 30 days.